Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/9/2025

Management of Disseminated Intravascular Coagulation (DIC)

Core Management Algorithm

  • The International Society on Thrombosis and Haemostasis (ISTH) recommends treating the underlying disease process as the cornerstone of therapy for DIC, addressing the root cause of the coagulopathy 1, 2
  • In cancer-associated DIC, the ISTH guidelines suggest initiating appropriate cancer therapy immediately, such as chemotherapy, surgery, or radiation as indicated 1, 2
  • For acute promyelocytic leukemia, early initiation of all-trans retinoic acid achieves good resolution of DIC, as recommended by the ISTH 3
  • In sepsis-associated DIC, source control and appropriate antibiotics are essential, according to the ISTH guidelines 4

Classification and Management of DIC Subtypes

  • The ISTH classifies DIC into three distinct forms: procoagulant DIC (thrombosis predominates), hyperfibrinolytic DIC (bleeding predominates), and subclinical DIC, each requiring different management approaches 5, 6
  • Procoagulant DIC is common in pancreatic cancer and adenocarcinomas, presenting with arterial ischemia, venous thromboembolism, or microvascular thrombosis, as described by the ISTH 5, 7, 6
  • Hyperfibrinolytic DIC is typical of acute promyelocytic leukemia and metastatic prostate cancer, presenting with widespread bleeding from multiple sites, according to the ISTH 5, 7, 6

Supportive Hemostatic Measures

  • The ISTH recommends maintaining a platelet count >50×10⁹/L through platelet transfusions for active bleeding 3, 4, 8
  • For prolonged coagulation times, the ISTH suggests administering 15-30 mL/kg of fresh frozen plasma (FFP) 3, 4, 8
  • The ISTH recommends replacing fibrinogen with cryoprecipitate or fibrinogen concentrate if levels remain <1.5 g/L despite FFP 3, 4, 8

Anticoagulation Strategy

  • The ISTH recommends initiating prophylactic anticoagulation with heparin in all patients except those with hyperfibrinolytic DIC, unless contraindications exist 1, 2, 9, 3
  • The ISTH suggests using low molecular weight heparin (LMWH) as the first choice for most patients 3
  • The ISTH recommends escalating to therapeutic-dose anticoagulation if arterial or venous thrombosis develops 1, 2, 9

Monitoring and Special Clinical Scenarios

  • The ISTH recommends monitoring complete blood count and coagulation screen (including fibrinogen and D-dimer) regularly, with frequency ranging from daily in acute severe DIC to monthly in chronic stable DIC 10, 7, 3
  • A 30% or greater drop in platelet count is diagnostic of subclinical DIC, even when absolute values remain normal, according to the ISTH 10, 7, 8
  • The ISTH suggests considering temporary IVC filter placement in patients who cannot be anticoagulated but have proximal lower limb thrombosis likely to embolize 1, 2

Management of Disseminated Intravascular Coagulation (DIC) in the ICU

Diagnostic Approach

  • The International Society on Thrombosis and Haemostasis (ISTH) recommends using a two-step sequential screening approach to identify patients who will benefit from specific therapies, first screening for Sepsis-Induced Coagulopathy (SIC) using the ISTH SIC score (≥4 points indicates SIC), and then applying the ISTH overt DIC score (≥5 points indicates overt DIC) for patients with more advanced coagulopathy 11, 12
  • The ISTH scoring components include platelet count, PT ratio, fibrinogen, D-dimer/FDP, and SOFA score (for SIC) 11, 12
  • Sequential screening on ICU admission day and 2 days later is associated with lower mortality 11

Anticoagulation Strategy Details

  • Anticoagulant therapy may improve outcomes specifically in septic patients with coagulopathy or DIC, though evidence remains controversial 11, 12
  • The ISTH suggests that patients with advanced overt DIC may have illness progression no longer amenable to anticoagulant therapy benefit 11

REFERENCES

3

Manejo de la Coagulación Intravascular Diseminada (CID) [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Management of Disseminated Intravascular Coagulation in Acute-on-Chronic Liver Failure [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

8

Disseminated Intravascular Coagulation in Acute Lymphoblastic Leukemia [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025